Analysis of defective pathways and drug repositioning in Multiple Sclerosis via machine learning approaches
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 115, 103492
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)BMC Immunology, 2013
- Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort studyBrain, 2013
- Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular MechanismsInternational Journal of Molecular Sciences, 2012
- Multiple Sclerosis Risk Variant HLA-DRB1*1501 Associates with High Expression of DRB1 Gene in Different Human PopulationsPLOS ONE, 2012
- Genetics of multiple sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressorBlood, 2010
- Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological eventProceedings of the National Academy of Sciences, 2008
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- VII. Note on regression and inheritance in the case of two parentsProceedings of the Royal Society of London, 1895